Singapore, Sept. 13 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More
Singapore, Sept. 13 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the e... Read More
Singapore, Sept. 13 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More
Tokyo, Sept. 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062900) titled 'Individualized risk prediction of inferior alveolar nerve injury after man... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132341) titled 'A Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Tri... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132340) titled 'Research on the Nursing Pathway for Vascular Crisis After Microsurgery' ... Read More
Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132342) titled 'Acute Postoperative Pain Trajectory Subtypes in Patients Undergoing Elec... Read More
Singapore, Sept. 12 -- The Health Sciences Authority received information related to the study titled 'RASolute 303: A Phase 3 Global, Multicenter, Open-label, Randomized, 3-Arm Study of Daraxonrasib ... Read More
Singapore, Sept. 12 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pemb... Read More
Singapore, Sept. 12 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eva... Read More